In this project, Dr Daniel Llano at University of Illinois aims to better understand whether and how hearing loss contributes to Alzheimer's disease. Project start date: September 2026 Project end date: September 2029 About the project We still don’t fully understand the connection between hearing loss and Alzheimer’s disease....
✦ Clinical Takeaway ✦
No actionable change — this is a newly funded research project with no results yet.
✦ Why It Matters ✦
Understanding whether APOE4 mechanistically links hearing loss to Alzheimer's pathology could reshape how audiologists counsel high-risk patients and prioritise early intervention.
✦ Key Points ✦
- 01RNID-funded project running Sept 2026–2029 at the University of Illinois.
- 02Led by Dr Daniel Llano; investigates APOE4 gene expression as a possible bridge between hearing loss and Alzheimer's.
- 03APOE4 is the strongest known genetic risk factor for late-onset Alzheimer's disease.
- 04Study is in the grant-announcement stage — no data or findings are available yet.
- 05Outcomes could inform future genetic counselling within audiology practice.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
APOE4 expression may link hearing loss to Alzheimer's disease pathology.
opinionunclear